Celastrol suppressed both constitutive and stimulated STAT3 activation in hepatocellular carcinoma, and this inhibition was mediated by inhibiting the expression of upstream kinase c-Src and Janus-activated kinase-1 and -2. This evidence concerns the gene STAT3 and hepatocellular carcinoma.